A carregar...

Evolving Personalized Therapy for Castration-Resistant Prostate Cancer

With advances in molecular biologic and genomic technology, detailed molecular mechanisms for development of castration-resistant prostate cancer (CRPC) have surfaced. Metastatic prostate cancer (PCa) no longer represents an end stage, with many emerging therapeutic agents approved as effective in p...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomedicine (Taipei)
Main Authors: Liu, Hsin-Ho, Tsai, Yuh-Shyan, Lai, Chen-Li, Tang, Chih-Hsin, Lai, Chih-Ho, Wu, Hsi-Chin, Hsieh, Jer-Tsong, Yang, Che-Rei
Formato: Artigo
Idioma:Inglês
Publicado em: China Medical University 2014
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4264971/
https://ncbi.nlm.nih.gov/pubmed/25520915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7603/s40681-014-0002-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!